ArticleTransfusion2020

Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.

Christopher Wallenhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.